New Supernus Pharmaceuticals Headquarters and Laboratories
“We’ve evolved from a start-up company to a mid-level pharmaceutical company, and we’re trying to create a new environment to reflect that,” says Frank Mottola, VP of Quality, GMP Operations and IT. (American Builders Quarterly)
Supernus Pharmaceutical’s new headquarters is located at 9715 Key West Avenue in Rockville, Maryland. They develop and market proprietary drugs for the treatment of central nervous system diseases and disorders. At this particular location, they manufacture the following three leading prescriptions:
Trokendi XR for migraine prevention
Oxtellar XR for onset seizures
Development of their newest drug is a non-stimulant ADHD medication. This is innovative because physicians can now provide a prescription for ADHD without controlled substances being involved.
Mottola is working to incorporate more technology into the spaces. (American Builders Quarterly)
Coakley & Williams Construction (CWC) was awarded the interior construction of the 120,000 sf laboratory and office space as the general contractor. We worked with DNC Architects on the design and with CFR Engineering for MEP coordination.
Building Supernus
30,000 sf of lab space
90,000 sf of office space
Contract value of $12 million
The Supernus Pharmaceuticals headquarters was built in two phases so office personnel could move into the space prior to the laboratory personnel. The first phase began in late April 2019 and was substantially completed in January 2020. We would like to thank the CWC team for working diligently on this project from beginning to end: Scott Carnegie, Luis Garcia, Alexa Liddic, Monique Joseph and Ada Contreras as well as our partners and subcontractors.
